MedTrace Logo

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

NCT06377527 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-12-26

No results posted yet for this study

Summary

To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.

Conditions

  • Mesonephric-like Adenocarcinoma

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Jeffrey How, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-10
Primary Completion
2035-12-28
Completion
2037-12-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06377527 on ClinicalTrials.gov